Rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by sequential use of nilotinib and imatinib: A GIMEMA protocol LAL 1408.

Authors

null

Cristina Papayannidis

Institute of Hematology, Bologna, Italy

Cristina Papayannidis , Alfonso Piciocchi , Antonella Vitale , Ilaria Iacobucci , Simona Soverini , Francesco Di Raimondo , Stefania Paolini , Giovanni Pizzolo , Angelo Michele Carella , Mario Cazzola , Antonio Cuneo , Pietro Leoni , Mario Luppi , Enrica Morra , Giorgina Specchia , Loredana Elia , Robin Foa , Michele Baccarani , Giovanni Martinelli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Leukemia

Clinical Trial Registration Number

NCT01025505

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7025)

DOI

10.1200/jco.2013.31.15_suppl.7025

Abstract #

7025

Poster Bd #

17

Abstract Disclosures